Introducing 
Transforming Access to Patient Drug Assistance.
Transforming Access to Patient Drug Assistance.
Designed to streamline and simplify the complexities of manufacturer-sponsored drug assistance programs. RevenueRx is purpose-built for hospitals and health systems seeking to reduce administrative burden, ensure compliance, and help patients access the high-cost medications they need through free drug, copay, and foundation support.
Our comprehensive solution includes Full-Service Application Management, Seamless Free Drug Ordering & Compliance, and Copay & Foundation Program Coordination. Each component is designed to streamline drug assistance and improve financial and operational outcomes for hospitals and health systems.
Rising specialty drug costs, recent Medicare reforms, and accumulator programs are leaving many patients—especially those on Medicare Part B or commercial plans—with significant out-of-pocket expenses. RevenueRx helps providers address these challenges by reducing administrative burden, ensuring billing compliance, improving revenue capture from assistance programs, and increasing access to life-saving medications for patients in need.
RevenueRx is supported by Panacea’s experienced staff and proprietary technology platform. We provide hospitals with clear, recurring reporting—tracking patient eligibility, approvals, recoveries, drug shipments, and compliance milestones. The result? Better patient access, better financial outcomes, and peace of mind for your team.
Whether your organization is launching a patient assistance initiative or looking to improve an existing one, RevenueRx offers a proven, scalable, and cost-effective solution. Let Panacea help you turn patient need into program success—without adding workload to your staff.
RevenueRx manages the end-to-end submission and tracking of patient assistance applications to pharmaceutical manufacturers and charitable foundations. Our team proactively screens eligible patients and ensures timely, accurate submission for free drug, copay, and foundation funding.